Executive compensation at private life science companies in troubled economic times
Nat Biotechnol
.
2009 Jan;27(1):98-9.
doi: 10.1038/nbt0109-98.
Authors
Bruce Rychlik
1
,
Mike DiPierro
Affiliation
1
J. Robert Scott, 260 Franklin Street, Suite 620, Boston, Massachusetts 02110, USA.
[email protected]
PMID:
19132000
DOI:
10.1038/nbt0109-98
No abstract available
MeSH terms
Biotechnology / economics*
Economic Competition / economics*
Industry / economics
Leadership
Private Sector / economics*
Salaries and Fringe Benefits / economics*
Workforce